Literature DB >> 11517290

The use of amplified cDNA to investigate the expression of seven imprinted genes in human oocytes and preimplantation embryos.

A Salpekar1, J Huntriss, V Bolton, M Monk.   

Abstract

Imprinted genes are characterized by expression of only one of the two alleles according to its inheritance from the mother or the father. This mono-allelic expression must arise from primary differential epigenetic modification of the parental alleles of the imprinted gene in the spermatozoon and the oocyte. Most of the information on the onset of imprinted gene expression, and on the molecular mechanisms regulating mono-allelic expression, have been derived from studies in the mouse. In this paper, we investigate the expression of seven imprinted genes in human preimplantation development. Due to limitations imposed by the rarity of human embryos available for research, our approach has been to screen amplified cDNA preparations prepared from human unfertilized oocytes and individual embryos at each of the 4-cell, 8-cell and blastocyst stages. Gene-specific primers were used to investigate expression of the imprinted genes by polymerase chain reaction (PCR) analysis of these amplified cDNA. We found that expression is inherently variable in the amplified cDNA from embryo to embryo but the use of several samples at each stage showed that the SNRPN, UBE3A and PEG1 genes are expressed throughout human preimplantation development. This was confirmed by direct analysis by gene-specific reverse transcription-PCR on a limited number of lysed embryos (one gene analysed per embryo). Thus, the amplified cDNA may be used to rapidly identify those imprinted genes expressed in preimplantation development and, hence, those genes amenable to investigation of the epigenetic mechanisms regulating mono-allelic expression. Confirmation of preimplantation expression also identifies those imprinted diseases amenable to preimplantation diagnosis, and the imprinted genes which may be used in assessment of possible perturbations of imprinting following new procedures in assisted reproduction. Our series of single embryo amplified cDNA are established as a valuable resource for comparative studies of gene expression within one embryo and between embryos throughout early human development. The amplified cDNA thus circumvent the need for a continuous supply of human embryos for studies on embryonic gene expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517290     DOI: 10.1093/molehr/7.9.839

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  5 in total

1.  Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines.

Authors:  Kee-Pyo Kim; Alexandra Thurston; Christine Mummery; Dorien Ward-van Oostwaard; Helen Priddle; Cinzia Allegrucci; Chris Denning; Lorraine Young
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

2.  The human cumulus--oocyte complex gene-expression profile.

Authors:  Said Assou; Tal Anahory; Véronique Pantesco; Tanguy Le Carrour; Franck Pellestor; Bernard Klein; Lionel Reyftmann; Hervé Dechaud; John De Vos; Samir Hamamah
Journal:  Hum Reprod       Date:  2006-03-29       Impact factor: 6.918

3.  The transcriptome of human oocytes.

Authors:  Arif Murat Kocabas; Javier Crosby; Pablo J Ross; Hasan H Otu; Zeki Beyhan; Handan Can; Wai-Leong Tam; Guilherme J M Rosa; Robert G Halgren; Bing Lim; Emilio Fernandez; Jose Bernardo Cibelli
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

4.  Variable imprinting of the MEST gene in human preimplantation embryos.

Authors:  John D Huntriss; Karen E Hemmings; Matthew Hinkins; Anthony J Rutherford; Roger G Sturmey; Kay Elder; Helen M Picton
Journal:  Eur J Hum Genet       Date:  2012-07-04       Impact factor: 4.246

Review 5.  Assisted reproduction treatment and epigenetic inheritance.

Authors:  A P A van Montfoort; L L P Hanssen; P de Sutter; S Viville; J P M Geraedts; P de Boer
Journal:  Hum Reprod Update       Date:  2012-01-19       Impact factor: 15.610

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.